Trial Profile
A Phase I clinical trial in healthy volunteers to evaluate a TRPC4/5 inhibitor.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2017
Price :
$35
*
At a glance
- Drugs BI 1358894 (Primary)
- Indications Anxiety disorders; CNS disorders; Depression
- Focus Adverse reactions
- 07 Nov 2017 New trial record